{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:59:29Z","timestamp":1788998369489,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["AR21715C7C7361C1"],"award-info":[{"award-number":["AR21715C7C7361C1"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00109-023-02307-6","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T14:03:09Z","timestamp":1680098589000},"page":"569-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis"],"prefix":"10.1007","volume":"101","author":[{"given":"Daniela","family":"Impellizzeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Maftei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Balboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Siracusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Cordaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6377-9256","authenticated-orcid":false,"given":"Roberta","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"2307_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/bmj.324.7333.312","volume":"324","author":"P Emery","year":"2002","unstructured":"Emery P, Buch M (2002) Treating rheumatoid arthritis with tumour necrosis factor alpha blockade. BMJ 324:312\u2013313. https:\/\/doi.org\/10.1136\/bmj.324.7333.312","journal-title":"BMJ"},{"key":"2307_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/s0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376:1094\u20131108. https:\/\/doi.org\/10.1016\/s0140-6736(10)60826-4","journal-title":"Lancet"},{"key":"2307_CR3","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3899\/jrheum.130493","volume":"40","author":"MLE Andersson","year":"2013","unstructured":"Andersson MLE, Svensson B, Bergman S (2013) Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years. J Rheumatol 40:1977\u20131985. https:\/\/doi.org\/10.3899\/jrheum.130493","journal-title":"J Rheumatol"},{"key":"2307_CR4","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.40879","volume":"71","author":"MA Shelef","year":"2019","unstructured":"Shelef MA (2019) New relationships for old autoantibodies in rheumatoid arthritis. Arthritis Rheumatol 71:1396\u20131399. https:\/\/doi.org\/10.1002\/art.40879","journal-title":"Arthritis Rheumatol"},{"key":"2307_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/itt.S243636","volume":"9","author":"NM Elemam","year":"2020","unstructured":"Elemam NM, Hannawi S, Maghazachi AA (2020) Role of chemokines and chemokine receptors in rheumatoid arthritis. Immunotargets Ther 9:43\u201356. https:\/\/doi.org\/10.2147\/itt.S243636","journal-title":"Immunotargets Ther"},{"issue":"20","key":"2307_CR6","doi-asserted-by":"publisher","first-page":"10922","DOI":"10.3390\/ijms222010922","volume":"22","author":"N Kondo","year":"2021","unstructured":"Kondo N, Kuroda T, Kobayashi D (2021) Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci 22(20):10922. https:\/\/doi.org\/10.3390\/ijms222010922","journal-title":"Int J Mol Sci"},{"key":"2307_CR7","doi-asserted-by":"publisher","first-page":"3830212","DOI":"10.1155\/2020\/3830212","volume":"2020","author":"Q Fang","year":"2020","unstructured":"Fang Q, Zhou C, Nandakumar KS (2020) Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediators Inflamm 2020:3830212. https:\/\/doi.org\/10.1155\/2020\/3830212","journal-title":"Mediators Inflamm"},{"key":"2307_CR8","doi-asserted-by":"publisher","unstructured":"Negri L, Lattanzi R (2011) Bv8-prokineticins and their receptors: modulators of pain. Curr Pharma Biotechnol 12:1720\u20131727. https:\/\/doi.org\/10.2174\/138920111798357410","DOI":"10.2174\/138920111798357410"},{"key":"2307_CR9","doi-asserted-by":"crossref","unstructured":"Negri L, Ferrara N (2018) The prokineticins: neuromodulators and mediators of inflammation","DOI":"10.1152\/physrev.00012.2017"},{"key":"2307_CR10","doi-asserted-by":"publisher","unstructured":"Negri L, Maftei D (2018) Targeting the prokineticin system to control chronic pain and inflammation. Curr Med Chem 25:3883\u20133894. https:\/\/doi.org\/10.2174\/0929867324666170713102514","DOI":"10.2174\/0929867324666170713102514"},{"key":"2307_CR11","doi-asserted-by":"publisher","unstructured":"Maftei D, Vellani V, Artico M, Giacomoni C, Severini C, Lattanzi R (2020) Abnormal pain sensation in mice lacking the prokineticin receptor PKR2: interaction of PKR2 with transient receptor potential TRPV1 and TRPA1. Neurosci 427:16\u201328. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.12.003","DOI":"10.1016\/j.neuroscience.2019.12.003"},{"key":"2307_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.bjp.0706467","volume":"147","author":"C Martucci","year":"2006","unstructured":"Martucci C, Franchi S, Giannini E, Tian H, Melchiorri P, Negri L, Sacerdote P (2006) Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages. Br J Pharmacol 147:225\u2013234. https:\/\/doi.org\/10.1038\/sj.bjp.0706467","journal-title":"Br J Pharmacol"},{"key":"2307_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2172-9-60","volume":"9","author":"S Franchi","year":"2008","unstructured":"Franchi S, Giannini E, Lattuada D, Lattanzi R, Tian H, Melchiorri P, Negri L, Panerai AE, Sacerdote P (2008) The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1. BMC Immunol 9:60. https:\/\/doi.org\/10.1186\/1471-2172-9-60","journal-title":"BMC Immunol"},{"key":"2307_CR14","doi-asserted-by":"publisher","first-page":"15301","DOI":"10.1038\/srep15301","volume":"5","author":"C Severini","year":"2015","unstructured":"Severini C, Lattanzi R, Maftei D, Marconi V, Ciotti MT, Petrocchi Passeri P, Florenzano F, Del Duca E, Caioli S, Zona C et al (2015) Bv8\/prokineticin 2 is involved in A\u03b2-induced neurotoxicity. Sci Rep 5:15301. https:\/\/doi.org\/10.1038\/srep15301","journal-title":"Sci Rep"},{"key":"2307_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuropharm.2016.12.012","volume":"116","author":"S Caioli","year":"2017","unstructured":"Caioli S, Severini C, Ciotti T, Florenzano F, Pimpinella D, Petrocchi Passeri P, Balboni G, Polisca P, Lattanzi R, Nistic\u00f2 R et al (2017) Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer\u2019s disease. Neuropharmacology 116:82\u201397. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.12.012","journal-title":"Neuropharmacology"},{"key":"2307_CR16","doi-asserted-by":"publisher","unstructured":"Lattanzi R, Maftei D, Petrella C, Pieri M, Sancesario G, Schirinzi T, Bernardini S, Barbato C, Ralli M, Greco A et al (2019a) Involvement of the chemokine prokineticin-2 (PROK2) in Alzheimer\u2019s disease: from animal models to the human pathology. Cells 8. https:\/\/doi.org\/10.3390\/cells8111430","DOI":"10.3390\/cells8111430"},{"key":"2307_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.npep.2018.11.006","volume":"73","author":"R Lattanzi","year":"2019","unstructured":"Lattanzi R, Maftei D, Fullone MR, Miele R (2019) Identification and characterization of prokineticin receptor 2 splicing variant and its modulation in an animal model of Alzheimer\u2019s disease. Neuropeptides 73:49\u201356. https:\/\/doi.org\/10.1016\/j.npep.2018.11.006","journal-title":"Neuropeptides"},{"key":"2307_CR18","doi-asserted-by":"publisher","unstructured":"Maftei D, Ratano P, Fusco I, Marconi V, Squillace S, Negri L, Severini C, Balboni G, Steardo L, Bronzuoli MR et al (2019) The prokineticin receptor antagonist PC1 rescues memory impairment induced by \u03b2 amyloid administration through the modulation of prokineticin system. Neuropharmacol 158:107739. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107739","DOI":"10.1016\/j.neuropharm.2019.107739"},{"key":"2307_CR19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/mds.28458","volume":"36","author":"T Schirinzi","year":"2021","unstructured":"Schirinzi T, Maftei D, Pieri M, Bernardini S, Mercuri NB, Lattanzi R, Severini C (2021) Increase of prokineticin-2 in serum of patients with Parkinson\u2019s disease. Mov Disord 36:1031\u20131033. https:\/\/doi.org\/10.1002\/mds.28458","journal-title":"Mov Disord"},{"key":"2307_CR20","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/biomedicines9111648","volume":"9","author":"R Lattanzi","year":"2021","unstructured":"Lattanzi R, Miele R (2021) Versatile role of prokineticins and prokineticin receptors in neuroinflammation. Biomedicines 9:1648. https:\/\/doi.org\/10.3390\/biomedicines9111648","journal-title":"Biomedicines"},{"key":"2307_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/cne.21087","volume":"498","author":"MY Cheng","year":"2006","unstructured":"Cheng MY, Leslie FM, Zhou QY (2006) Expression of prokineticins and their receptors in the adult mouse brain. J Comp Neurol 498:796\u2013809. https:\/\/doi.org\/10.1002\/cne.21087","journal-title":"J Comp Neurol"},{"key":"2307_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/157015906778019518","volume":"4","author":"L Negri","year":"2006","unstructured":"Negri L, Lattanzi R, Giannini E, Melchiorri P (2006) Modulators of pain: Bv8 and prokineticins. Curr Neuropharmacol 4:207\u2013215. https:\/\/doi.org\/10.2174\/157015906778019518","journal-title":"Curr Neuropharmacol"},{"key":"2307_CR23","doi-asserted-by":"publisher","first-page":"14646","DOI":"10.1073\/pnas.0903720106","volume":"106","author":"E Giannini","year":"2009","unstructured":"Giannini E, Lattanzi R, Nicotra A, Campese AF, Grazioli P, Screpanti I, Balboni G, Salvadori S, Sacerdote P, Negri L (2009) The chemokine Bv8\/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc Natl Acad Sci U S A 106:14646\u201314651. https:\/\/doi.org\/10.1073\/pnas.0903720106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2307_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2474-10-45","volume":"10","author":"D Kurosaka","year":"2009","unstructured":"Kurosaka D, Noda K, Yoshida K, Furuya K, Ukichi T, Takahashi E, Yanagimachi M, Kingetsu I, Saito S, Yamada A (2009) Elevation of Bombina variegata peptide 8 in mice with collagen-induced arthritis. BMC Musculoskelet Disord 10:45. https:\/\/doi.org\/10.1186\/1471-2474-10-45","journal-title":"BMC Musculoskelet Disord"},{"key":"2307_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12891-016-1243-0","volume":"17","author":"H Ito","year":"2016","unstructured":"Ito H, Noda K, Yoshida K, Otani K, Yoshiga M, Oto Y, Saito S, Kurosaka D (2016) Prokineticin 2 antagonist, PKRA7 suppresses arthritis in mice with collagen-induced arthritis. BMC Musculoskelet Disord 17:387. https:\/\/doi.org\/10.1186\/s12891-016-1243-0","journal-title":"BMC Musculoskelet Disord"},{"key":"2307_CR26","doi-asserted-by":"publisher","first-page":"18399","DOI":"10.1038\/s41598-021-97809-z","volume":"11","author":"K Noda","year":"2021","unstructured":"Noda K, Dufner B, Ito H, Yoshida K, Balboni G, Straub RH (2021) Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis. Sci Rep 11:18399. https:\/\/doi.org\/10.1038\/s41598-021-97809-z","journal-title":"Sci Rep"},{"key":"2307_CR27","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.1021\/jm800854e","volume":"51","author":"G Balboni","year":"2008","unstructured":"Balboni G, Lazzari I, Trapella C, Negri L, Lattanzi R, Giannini E, Nicotra A, Melchiorri P, Visentin S, Nuccio CD, Salvadori S (2008) Triazine compounds as antagonists at Bv8-prokineticin receptors. J Med Chem 51:7635\u20137639. https:\/\/doi.org\/10.1021\/jm800854e","journal-title":"J Med Chem"},{"key":"2307_CR28","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1111\/bph.12793","volume":"171","author":"D Maftei","year":"2014","unstructured":"Maftei D, Marconi V, Florenzano F, Giancotti LA, Castelli M, Moretti S, Borsani E, Rodella LF, Balboni G, Luongo L et al (2014) Controlling the activation of the Bv8\/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals. Br J Pharmacol 171:4850\u20134865. https:\/\/doi.org\/10.1111\/bph.12793","journal-title":"Br J Pharmacol"},{"key":"2307_CR29","doi-asserted-by":"publisher","unstructured":"Lattanzi R, Maftei D, Marconi V, Florenzano F, Franchi S, Borsani E, Rodella LF, Balboni G, Salvadori S, Sacerdote P et al (2015) Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model. Biomed Res Int 2015:301292. https:\/\/doi.org\/10.1155\/2015\/301292","DOI":"10.1155\/2015\/301292"},{"key":"2307_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.phrs.2014.11.004","volume":"91","author":"F Guida","year":"2015","unstructured":"Guida F, Lattanzi R, Boccella S, Maftei D, Romano R, Marconi V, Balboni G, Salvadori S, Scafuro MA, de Novellis V et al (2015) PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice. Pharmacol Res 91:36\u201346. https:\/\/doi.org\/10.1016\/j.phrs.2014.11.004","journal-title":"Pharmacol Res"},{"key":"2307_CR31","doi-asserted-by":"publisher","unstructured":"Castelli M, Amodeo G, Negri L, Lattanzi R, Maftei D, Gotti C, Pistillo F, Onnis V, Congu C, Panerai AE et al (2016) Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes. PLoS One 11:e0146259. https:\/\/doi.org\/10.1371\/journal.pone.0146259","DOI":"10.1371\/journal.pone.0146259"},{"key":"2307_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-019-1461-0","volume":"16","author":"G Moschetti","year":"2019","unstructured":"Moschetti G, Amodeo G, Maftei D, Lattanzi R, Procacci P, Sartori P, Balboni G, Onnis V, Conte V, Panerai A et al (2019) Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy. J Neuroinflammation 16:89. https:\/\/doi.org\/10.1186\/s12974-019-1461-0","journal-title":"J Neuroinflammation"},{"key":"2307_CR33","doi-asserted-by":"publisher","unstructured":"Impellizzeri D, Siracusa R, Cordaro M, Peritore AF, Gugliandolo E, D'amico R, Fusco R, Crupi R, Rizzarelli E, Cuzzocrea S et al (2020) Protective effect of a new hyaluronic acid -carnosine conjugate on the modulation of the inflammatory response in mice subjected to collagen-induced arthritis.\u00a0Biomed Pharmacother 125:110023. https:\/\/doi.org\/10.1016\/j.biopha.2020.110023","DOI":"10.1016\/j.biopha.2020.110023"},{"issue":"7","key":"2307_CR34","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1073\/pnas.95.7.3867","volume":"95","author":"C Szab\u00f3","year":"1998","unstructured":"Szab\u00f3 C, Vir\u00e1g L, Cuzzocrea S, Scott GS, Hake P, O\u2019Connor MP, Zingarelli B, Salzman A, Kun E (1998) Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci U S A 95(7):3867\u20133872. https:\/\/doi.org\/10.1073\/pnas.95.7.3867","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2307_CR35","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/sj.bjp.0701971","volume":"124","author":"L Negri","year":"1998","unstructured":"Negri L, Lattanzi R, Tabacco F, Scolaro B, Rocchi R (1998) Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration. Br J Pharmacol 124:1516\u20131522. https:\/\/doi.org\/10.1038\/sj.bjp.0701971","journal-title":"Br J Pharmacol"},{"key":"2307_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","volume":"32","author":"K Hargreaves","year":"1988","unstructured":"Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77\u201388. https:\/\/doi.org\/10.1016\/0304-3959(88)90026-7","journal-title":"Pain"},{"key":"2307_CR37","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1186\/ar4382","volume":"15","author":"D Impellizzeri","year":"2013","unstructured":"Impellizzeri D, Esposito E, Di Paola R, Ahmad A, Campolo M, Peli A, Morittu VM, Britti D, Cuzzocrea S (2013) Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. Arthritis Res Ther 15:4055. https:\/\/doi.org\/10.1186\/ar4382","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 1","key":"2307_CR38","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.freeradbiomed.2014.10.816","volume":"75","author":"W Luczaj","year":"2014","unstructured":"Luczaj W, Jarocka-Karpinska I, Sierakowski S, Andrisic L, Zarkovic N, Skrzydlewska E (2014) Lipid peroxidation in rheumatoid arthritis; consequences and monitoring. Free Radic Biol Med 75(Suppl 1):S49. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.10.816","journal-title":"Free Radic Biol Med"},{"key":"2307_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"key":"2307_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.intimp.2017.03.011","volume":"46","author":"IA Choi","year":"2017","unstructured":"Choi IA, Choi JY, Jung S, Basri F, Park S, Lee EY (2017) GV1001 immunotherapy ameliorates joint inflammation in a murine model of rheumatoid arthritis by modifying collagen-specific T-cell responses and downregulating antigen-presenting cells. Int Immunopharmacol 46:186\u2013193. https:\/\/doi.org\/10.1016\/j.intimp.2017.03.011","journal-title":"Int Immunopharmacol"},{"key":"2307_CR41","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.bbi.2012.07.021","volume":"26","author":"A Ahmad","year":"2012","unstructured":"Ahmad A, Crupi R, Impellizzeri D, Campolo M, Marino A, Esposito E, Cuzzocrea S (2012) Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. Brain Behav Immun 26:1310\u20131321. https:\/\/doi.org\/10.1016\/j.bbi.2012.07.021","journal-title":"Brain Behav Immun"},{"key":"2307_CR42","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1002\/art.11351","volume":"48","author":"S Cuzzocrea","year":"2003","unstructured":"Cuzzocrea S, Mazzon E, Dugo L, Patel NS, Serraino I, Di Paola R, Genovese T, Britti D, De Maio M, Caputi AP, Thiemermann C (2003) Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Arthritis Rheum 48:3544\u20133556. https:\/\/doi.org\/10.1002\/art.11351","journal-title":"Arthritis Rheum"},{"key":"2307_CR43","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1172\/jci36389","volume":"118","author":"FM Brennan","year":"2008","unstructured":"Brennan FM, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537\u20133545. https:\/\/doi.org\/10.1172\/jci36389","journal-title":"J Clin Invest"},{"key":"2307_CR44","doi-asserted-by":"publisher","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23. Epub 2017 Jul 14. PMID: 29158945; PMCID: PMC5661633","DOI":"10.1038\/sigtrans.2017.23"},{"issue":"2","key":"2307_CR45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/life12020172","volume":"12","author":"R Lattanzi","year":"2022","unstructured":"Lattanzi R, Miele R (2022) Prokineticin-receptor network: mechanisms of regulation Life (Basel) 12(2):172. https:\/\/doi.org\/10.3390\/life12020172","journal-title":"Prokineticin-receptor network: mechanisms of regulation Life (Basel)"},{"key":"2307_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bcmd.2005.06.001","volume":"35","author":"D Kurosaka","year":"2005","unstructured":"Kurosaka D, Yasuda J, Yoshida K, Yasuda C, Toyokawa Y, Yokoyama T, Kingetsu I, Yamada A (2005) Kinetics of circulating endothelial progenitor cells in mice with type II collagen arthritis. Blood Cells Mol Dis 35:236\u2013240. https:\/\/doi.org\/10.1016\/j.bcmd.2005.06.001","journal-title":"Blood Cells Mol Dis"},{"key":"2307_CR47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/03009740701605913","volume":"36","author":"D Kurosaka","year":"2007","unstructured":"Kurosaka D, Yoshida K, Yasuda J, Yasuda C, Noda K, Furuya K, Ukichi T, Kingetsu I, Joh K, Yamaguchi N et al (2007) The effect of endostatin evaluated in an experimental animal model of collagen-induced arthritis. Scand J Rheumatol 36:434\u2013441. https:\/\/doi.org\/10.1080\/03009740701605913","journal-title":"Scand J Rheumatol"},{"key":"2307_CR48","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1476-5381.2012.02191.x","volume":"168","author":"K Beale","year":"2013","unstructured":"Beale K, Gardiner JV, Bewick GA, Hostomska K, Patel NA, Hussain SS, Jayasena CN, Ebling FJ, Jethwa PH, Prosser HM et al (2013) Peripheral administration of prokineticin 2 potently reduces food intake and body weight in mice via the brainstem. Br J Pharmacol 168:403\u2013410. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02191.x","journal-title":"Br J Pharmacol"},{"key":"2307_CR49","doi-asserted-by":"publisher","unstructured":"Maftei D, Lattanzi R, Vincenzi M, Squillace S, Fullone MR, Miele R (2021) The balance of concentration between prokineticin 2\u03b2 and prokineticin 2 modulates the food intake by STAT3 signaling. BBA Advances 1:100028. https:\/\/doi.org\/10.1016\/j.bbadva.2021.100028","DOI":"10.1016\/j.bbadva.2021.100028"},{"key":"2307_CR50","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2249.2008.03634.x","volume":"152","author":"LI Filippin","year":"2008","unstructured":"Filippin LI, Vercelino R, Marroni NP, Xavier RM (2008) Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 152:415\u2013422. https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03634.x","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02307-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02307-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02307-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T08:03:38Z","timestamp":1683273818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02307-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2307"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02307-6","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was approved by the University of Messina Animal Treatment Review Board. The care of the animals complied with the new legislation for the safety of animals used for scientific purposes (D.Lgs 2014\/26 and EU Directive 2010\/63).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}